Skip to main content
Equibles

Joe Renda

Analyst

Specialty

Equibles does not estimate personal net worth.

About Joe Renda

Joe Renda is recorded as Analyst at Specialty. Joe Renda has spoken on 1 earnings call across 1 company, most recently for Amneal Pharmaceuticals, Inc. on February 27, 2026. The companies whose calls Joe Renda spoke on are classified in the Healthcare sector.

Joe Renda on recent calls

“And yeah, the response from the field team so far has been fantastic on both Crexon and Brachia auto-injector because what we're seeing in the market from the key KOLs has been very favorable.”
Analyst — Specialty, Amneal Pharmaceuticals, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

  • Specialty

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity